Influence of Growth Hormone (GH) Receptor Deletion of Exon 3 and Full-Length Isoforms on GH Response and Final Height in Patients with Severe GH Deficiency
Open Access
- 1 March 2008
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (3) , 974-980
Abstract
Context: A polymorphism of the GH receptor (GHR) gene resulting in genomic deletion of exon 3 (GHR-d3) has been associated with responsiveness to GH therapy. However, the data reported so far do vary according to the underlying condition, replacement dose, and duration of the treatment. Objective, Design: The aim of this study was to analyze the impact of the GHR genotypes in terms of the initial height velocity (HV) resulting from treatment and the impact upon adult height in patients suffering from severe isolated GH deficiency. Controls, Patients, Setting: A total of 181 subjects (peak stimulated GH ≤ 2 ng/ml) were studied. In addition, GHR genotype frequency was compared with a healthy adult control group. Interventions: Based on the various GHR genotypes, HV, effect of recombinant human GH dose used, and final height were analyzed. Main Outcome Measures, Results: In the 181 subjects after the first two yr on recombinant human GH treatment, HV sd score (SDS) as well as height gain were significantly greater in subjects with the GHR-d3/d3 genotype when compared with the subjects presenting with the GHR-full-length/full-length genotype (P < 0.05). A GHR-d3 allele dose-dependent effect was found for both HV SDS (r = 0.72) and height gain (r = 0.77). However, there was no significant difference in final adult height and height SDS according to the exon-3 genotypes. Conclusions: Our results indicate that in patients with severe isolated GH deficiency, although the GHR genotype might play a role in GH responsiveness, at least at the beginning of treatment, there is no effect on final height.Keywords
This publication has 22 references indexed in Scilit:
- The Growth Response to Growth Hormone (GH) Treatment in Children with Isolated GH Deficiency Is Independent of the Presence of the Exon 3-Minus Isoform of the GH ReceptorThe Journal of Clinical Endocrinology & Metabolism, 2006
- The d3/fl-Growth Hormone (GH) Receptor Polymorphism Does Not Influence the Effect of GH Treatment (66 μg/kg per Day) or the Spontaneous Growth in Short Non-GH-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study in 170 Spanish PatientsThe Journal of Clinical Endocrinology & Metabolism, 2006
- Effect of Growth Hormone (GH) Treatment on the Near-Final Height of 1258 Patients with Idiopathic GH Deficiency: Analysis of a Large International DatabaseThe Journal of Clinical Endocrinology & Metabolism, 2006
- A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormoneNature Genetics, 2004
- Species-specific Alternative Splice Mimicry at the Growth Hormone Receptor Locus Revealed by the Lineage of Retroelements during Primate EvolutionJournal of Biological Chemistry, 2000
- Growth1993
- Prevalence of Human Growth Hormone-1 Gene Deletions among Patients with Isolated Growth Hormone Deficiency from Different PopulationsPediatric Research, 1992
- The human growth hormone locus: Nucleotide sequence, biology, and evolutionGenomics, 1989
- Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height.Archives of Disease in Childhood, 1975
- Variations in the Pattern of Pubertal Changes in BoysArchives of Disease in Childhood, 1970